These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25255111)

  • 1. Proteomic analysis in serum of rat hind-limb allograft tolerance induced by immunosuppressive therapy with adipose-derived stem cells.
    Kuo YR; Chen CC; Goto S; Huang YT; Tsai CC; Yang MY
    Plast Reconstr Surg; 2014 Dec; 134(6):1213-1223. PubMed ID: 25255111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model.
    Kuo YR; Chen CC; Goto S; Lee IT; Huang CW; Tsai CC; Wang CT; Chen CL
    Plast Reconstr Surg; 2011 Dec; 128(6):661e-672e. PubMed ID: 22094768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell-derived mesenchymal stem cells prolong hind limb survival in a rat vascularized composite allotransplantation model.
    Mitsuzawa S; Ikeguchi R; Aoyama T; Ando M; Takeuchi H; Yurie H; Oda H; Noguchi T; Ohta S; Zhao C; Ikeya M; Matsuda S
    Microsurgery; 2019 Nov; 39(8):737-747. PubMed ID: 31471984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of a CD26 Inhibitor, G-CSF, and Short-term Immunosuppressants Modulates Allotransplant Survival and Immunoregulation in a Rodent Hindlimb Allotransplant Model.
    Chen CC; Chen RF; Wang YC; Li YT; Chuang JH; Kuo YR
    Transplantation; 2021 Jun; 105(6):1250-1260. PubMed ID: 33093401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
    Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine a therapy.
    Ozer K; Gurunluoglu R; Zielinski M; Izycki D; Unsal M; Siemionow M
    J Reconstr Microsurg; 2003 May; 19(4):249-56. PubMed ID: 12858248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
    Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
    Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK
    Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local Delivery of Adipose Stem Cells Promotes Allograft Survival in a Rat Hind-Limb Model of Vascularized Composite Allotransplantation.
    Zhang W; Lee PL; Li J; Komatsu C; Wang Y; Sun H; DeSanto M; Washington K; Gorantla V; Kokai L; Solari MG
    Plast Reconstr Surg; 2024 Jan; 153(1):79e-90e. PubMed ID: 37014960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation.
    Jindal R; Unadkat J; Zhang W; Zhang D; Ng TW; Wang Y; Jiang J; Lakkis F; Rubin P; Lee WP; Gorantla VS; Zheng XX
    Am J Transplant; 2015 May; 15(5):1231-40. PubMed ID: 25676865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient bone marrow-derived stromal cells prolong graft survival in a rat hind limb allotransplantation model.
    Ikeguchi R; Kakinoki R; Ohta S; Oda H; Yurie H; Kaizawa Y; Mitsui H; Aoyama T; Toguchida J; Matsuda S
    Microsurgery; 2017 Sep; 37(6):632-640. PubMed ID: 27859595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo allotransplantation engineering: Delivery of mesenchymal stem cells prolongs rejection-free allograft survival.
    Soares MA; Massie JP; Rifkin WJ; Rao N; Duckworth AM; Park C; Kadle RL; David JA; Rabbani PS; Ceradini DJ
    Am J Transplant; 2018 Jul; 18(7):1657-1667. PubMed ID: 29359512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model.
    Solari MG; Washington KM; Sacks JM; Hautz T; Unadkat JV; Horibe EK; Venkataramanan R; Larregina AT; Thomson AW; Lee WPA
    Plast Reconstr Surg; 2009 Feb; 123(2 Suppl):17S-25S. PubMed ID: 19182660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.